dostęp płatny
Fakty i mity na temat leków psychotropowych — wiedza studentów kierunków medycznych na temat leków psychotropowych
- Klinika Psychiatryczna, Wydział Nauki o Zdrowiu, Warszawski Uniwersytet Medyczny, Warszawa, Polska
- Mazowieckie Specjalistyczne Centrum Zdrowia im. Prof. Jana Mazurkiewicza, Pruszków, Polska
dostęp płatny
Streszczenie
Streszczenie
Pełny tekst:
Dodaj do koszyka: 49,00 PLNSłowa kluczowe
leki psychotropowe, wiedza o lekach, mity o lekach psychotropowych
Tytuł
Fakty i mity na temat leków psychotropowych — wiedza studentów kierunków medycznych na temat leków psychotropowych
Czasopismo
Numer
Typ artykułu
Praca badawcza (oryginalna)
Strony
12-21
Opublikowany online
2023-03-29
Wyświetlenia strony
383
Wyświetlenia/pobrania artykułu
59
DOI
Rekord bibliograficzny
Psychiatria 2023;20(1):12-21.
Słowa kluczowe
leki psychotropowe
wiedza o lekach
mity o lekach psychotropowych
Autorzy
Małgorzata Witek
Anna Mosiołek
- Krupa D, Czech M, Pinkas J, et al. Impact of COVID-19 pandemic on the use of antidepressant and antianxiety pharmaceuticals as well as sick leave in poland. Int J Environ Res Public Health. 2022; 19(4).
- Kompleksowe badanie stanu zdrowia psychicznego społeczeństwa i jego uwarunkowań (EZOP II). Wyniki badania. https://ezop.edu.pl/wyniki-badania (25.03.2023).
- Schulz P, Steimer T. Psychotropic medication, psychiatric disorders, and higher brain functions. Dialogues Clin Neurosci. 2000; 2(3): 177–182.
- Frank RG, Conti RM, Goldman HH. Mental health policy and psychotropic drugs. Milbank Q. 2005; 83(2): 271–298.
- Zohar J, Nutt DJ, Kupfer DJ, et al. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol. 2014; 24(7): 1005–1014.
- Möller HJ, Schmitt A, Falkai P. Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications. Eur Arch Psychiatry Clin Neurosci. 2016; 266(5): 385–386.
- Sathyanarayana Rao TS, Andrade C. Classification of psychotropic drugs: Problems, solutions, and more problems. Indian J Psychiatry. 2016; 58(2): 111–113.
- Worley L. Neuroscience-based nomenclature (NbN). Lancet Psychiatry. 2017; 4(4): 272–273.
- Caraci F, Enna SJ, Zohar J, et al. A new nomenclature for classifying psychotropic drugs. Br J Clin Pharmacol. 2017; 83(8): 1614–1616.
- Ghaemi SN. A new drug nomenclature for psychiatry — prospects and hazards. Br J Clin Pharmacol. 2017; 83(8): 1617–1618.
- Moncrieff J, Cohen D. How do psychiatric drugs work? BMJ. 2009; 338: b1963.
- Moncrieff J, Cohen D. Rethinking models of psychotropic drug action. Psychother Psychosom. 2005; 74(3): 145–153.
- Hyman SE. Psychiatric drug development: diagnosing a crisis. Cerebrum. 2013; 5.
- Hyman SE. New insights into how antipsychotic drugs might work. Harv Rev Psychiatry. 1993; 1(1): 68–69.
- Mizrahi R, Bagby RM, Zipursky RB, et al. How antipsychotics work: the patients' perspective. Prog Neuropsychopharmacol Biol Psychiatry. 2005; 29(5): 859–864.
- Campbell HM, Raisch DW, Mike R, et al. impact of a clinical trials information. IRB. 2008; 30(1): 6–14.
- Korzeniowska K, Balcer N, Jabłecka A. Monitoring drug side effects by reducing health risks. Probl Hig Epidemiol. 2009; 90(2): 223.
- Simoons M, Ruhé HG, van Roon EN, et al. Design and methods of the 'monitoring outcomes of psychiatric pharmacotherapy' (MOPHAR) monitoring program — a study protocol. BMC Health Serv Res. 2019; 19(1): 125.
- Mitchell P. Therapeutic drug monitoring of psychotropic medications. Br J Clin Pharmacol. 2008; 52(S1): 45–54.
- Mago R. Adverse effects of psychotropic medications: a call to action. Psychiatr Clin North Am. 2016; 39(3): 361–373.
- Grunze A, Mago R, Grunze H. Nebenwirkungen von psychopharmaka: tipps für die Praxis. DMW - Deutsche Medizinische Wochenschrift. 2017; 142(22): 1690–1700.
- Tueth MJ. Emergencies caused by side effects of psychiatric medications. Am J Emerg Med. 1994; 12(2): 212–216.
- Arkar H, Eker D. Influence of a 3-week psychiatric training programme on attitudes toward mental illness in medical students. Soc Psychiatry Psychiatr Epidemiol. 1997; 32(3): 171–176.
- Shen Y, Dong H, Fan X, et al. What can the medical education do for eliminating stigma and discrimination associated with mental illness among future doctors? effect of clerkship training on chinese students' attitudes. Int J Psychiatry Med. 2014; 47(3): 241–254.
- Fife SA, Ketzenberger KE, Olson JN. Attitudes toward psychotropic medications. Psychol Rep. 2012; 110(2): 475–476.
- Heskestad S, Kalhovde AM, Jakobsen ES, et al. Drug-free psychiatric treatment — what do the patients think? Tidsskr Nor Laegeforen. 2019; 139(14).
- Shahin SH, Daly EB. Knowledge, attitudes and beliefs about psychotropic medication among Saudi hospitalized psychiatric patients. Int J Nurs Stud. 1999; 36(1): 51–55.
- Omyła-Rudzka M. Stosunek do Osób Chorych Psychicznie. CBOS; Warsaw, Poland. 2012. https://cbos.pl/SPISKOM.POL/2012/K_147_12.PDF%20 (21.01.2023).
- Benkert O, Graf-Morgenstern M, Hillert A, et al. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J Nerv Ment Dis. 1997; 185(3): 151–158.
- Hillert A, Sandmann J, Ehmig SC, et al. Psychopharmaceutical drugs in the mass media. Results of a systematic analysis of text contents and images. Nervenarzt. 1995; 66(11): 835–44.
- Chikaodiri AN. Attitude of health workers to the care of psychiatric patients. Ann Gen Psychiatry. 2009; 8: 19.